Yukihiro Tateishi
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of KRAS(G12D) selective degrader ASP3082.
Journal: Communications chemistry
Published: February 12, 2025
Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency.
Journal: Bioorganic & medicinal chemistry
Published: November 27, 2020
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2.
Journal: Bioorganic & medicinal chemistry
Published: February 09, 2020
Correction to NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes.
Journal: Journal of medicinal chemistry
Published: July 14, 2018
NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes.
Journal: Journal of medicinal chemistry
Published: May 18, 2018
An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruzi.
Journal: Journal of medicinal chemistry
Published: February 17, 2016
In silico, in vitro, X-ray crystallography, and integrated strategies for discovering spermidine synthase inhibitors for Chagas disease.
Journal: Scientific reports
Published: February 05, 2016
Structural insights into the novel inhibition mechanism of Trypanosoma cruzi spermidine synthase.
Journal: Acta crystallographica. Section D, Biological crystallography
Published: March 23, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026